skip to main content
Washington State Institute for Public Policy
- Remove
- Remove
- Remove
From To
+ Add new line


Found 1 results

Long-Acting Injectable Medications for Alcohol and Opioid Use Disorders: Benefit-Cost Findings

Open Publication PDF

Mia Nafziger - December 2016

The 2015 Washington State Legislature directed WSIPP to review existing literature and begin a four-year study to evaluate outcomes regarding the cost-effectiveness of FDA-approved long-acting injectable medications, focusing on the benefits to persons in prison when they are released into the community.

We review the research evidence on the effectiveness of these medications in reducing substance abuse and recidivism rates. Where possible, we calculate whether the benefits of administering long-acting injectable medications outweigh the costs.

Report ID: 16-12-3901

Filter By Topic
Benefit-cost analysis
Children’s services
Criminal justice: Adult corrections
Criminal justice: Juvenile justice
General government
Health care
Higher education
Mental health
Pre-K-12 education
Public health
Substance abuse

Filter By Author
Madeline Barch
John Bauer
Kristofer Bitney
Julia Cramer
Adam Darnell
Sara del Moral
Elizabeth Drake
Danielle Fumia
Rebecca Goodvin
Lijian He
Casey Hicks
Michael Hirsch
Chasya Hoagland
Stephanie Lee
Marna Miller
Catherine Nicolai
Paige Wanner
Eva Westley
(show all authors)